Biocrede

Executive Summary

Biocrede is a US-based consulting and investment firm focused on supporting early-stage biotech and medical device startups. Founded in 2019 and headquartered in San Francisco, the company operates at the intersection of digital health and artificial intelligence, offering strategic advisory, non-dilutive R&D grant assistance, intellectual property development, and operational support. Additionally, Biocrede engages in direct investments and facilitates mergers and acquisitions within the biomedical startup ecosystem. By combining domain expertise with AI-driven insights, the firm aims to accelerate the growth of innovative healthcare ventures while reducing their capital constraints and operational risks.

Upcoming Catalysts (preview)

• Q3 2026Announcement of new strategic partnerships or client engagements in digital health60% success
• TBDCompletion of a notable M&A advisory mandate or direct investment in a high-growth biotech startup50% success
• Q4 2026Release of a white paper or case study demonstrating AI-driven grant success rates70% success